These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 35432823)
1. Establishment and Analysis of Hypoxia-Related Model in Oral Squamous Cell Carcinoma. Lu X; Liu X J Healthc Eng; 2022; 2022():6602648. PubMed ID: 35432823 [TBL] [Abstract][Full Text] [Related]
2. A Novel Immune-Related Gene Signature to Identify the Tumor Microenvironment and Prognose Disease Among Patients With Oral Squamous Cell Carcinoma Patients Using ssGSEA: A Bioinformatics and Biological Validation Study. Chen Y; Feng Y; Yan F; Zhao Y; Zhao H; Guo Y Front Immunol; 2022; 13():922195. PubMed ID: 35935989 [TBL] [Abstract][Full Text] [Related]
3. A four-hypoxia-genes-based prognostic signature for oral squamous cell carcinoma. Zhao C; Zhou Y; Ma H; Wang J; Guo H; Liu H BMC Oral Health; 2021 May; 21(1):232. PubMed ID: 33941139 [TBL] [Abstract][Full Text] [Related]
4. Gene Expression Clustering and Selected Head and Neck Cancer Gene Signatures Highlight Risk Probability Differences in Oral Premalignant Lesions. Carenzo A; Serafini MS; Roca E; Paderno A; Mattavelli D; Romani C; Saintigny P; Koljenović S; Licitra L; De Cecco L; Bossi P Cells; 2020 Aug; 9(8):. PubMed ID: 32756466 [TBL] [Abstract][Full Text] [Related]
5. Identification of Candidate Target Genes and Immune Cells in Oral Squamous Cell Carcinoma. Xie P; Wu S; Guo L; Ren J; Cai K; Zhou M; Liu W; Yang S Comput Math Methods Med; 2021; 2021():5802110. PubMed ID: 35003322 [TBL] [Abstract][Full Text] [Related]
6. Ferroptosis-associated DNA methylation signature predicts overall survival in patients with head and neck squamous cell carcinoma. Xu Y; Hong M; Kong D; Deng J; Zhong Z; Liang J BMC Genomics; 2022 Jan; 23(1):63. PubMed ID: 35042463 [TBL] [Abstract][Full Text] [Related]
7. A Prognostic Model Based on Cisplatin-Resistance Related Genes in Oral Squamous Cell Carcinoma. Lu R; Yang Q; Liu S; Sun L Oral Health Prev Dent; 2024 Jan; 22():39-50. PubMed ID: 38223960 [TBL] [Abstract][Full Text] [Related]
8. Development of a lncRNA-based prognostic signature for oral squamous cell carcinoma. Xu Z; Li X; Pan L; Tan R; Ji P; Tang H J Oral Pathol Med; 2022 Apr; 51(4):358-368. PubMed ID: 35100473 [TBL] [Abstract][Full Text] [Related]
9. A Five-mRNA Expression Signature to Predict Survival in Oral Squamous Cell Carcinoma by Integrated Bioinformatic Analyses. Guo H; Li C; Su X; Huang X Genet Test Mol Biomarkers; 2021 Aug; 25(8):517-527. PubMed ID: 34406843 [No Abstract] [Full Text] [Related]
10. Development and validation of a hypoxia-immune-based microenvironment gene signature for risk stratification in gastric cancer. Liu Y; Wu J; Huang W; Weng S; Wang B; Chen Y; Wang H J Transl Med; 2020 May; 18(1):201. PubMed ID: 32410620 [TBL] [Abstract][Full Text] [Related]
11. Development of a prediction model for radiotherapy response among patients with head and neck squamous cell carcinoma based on the tumor immune microenvironment and hypoxia signature. Zhu GL; Yang KB; Xu C; Feng RJ; Li WF; Ma J Cancer Med; 2022 Dec; 11(23):4673-4687. PubMed ID: 35505641 [TBL] [Abstract][Full Text] [Related]
12. Construction of a hypoxia-derived gene model to predict the prognosis and therapeutic response of head and neck squamous cell carcinoma. Wang H; Zheng L Sci Rep; 2022 Aug; 12(1):13538. PubMed ID: 35945448 [TBL] [Abstract][Full Text] [Related]
13. Identification of Prognostic and Tumor Microenvironment by Shelterin Complex-Related Signatures in Oral Squamous Cell Carcinoma. Zhang S; Yu H; Li J; Zhao L; Tan L; Song Q; Sun C Oxid Med Cell Longev; 2022; 2022():6849304. PubMed ID: 35757510 [TBL] [Abstract][Full Text] [Related]
14. Up-regulation of extracellular-matrix and inflammation related genes in oral squamous cell carcinoma. Thakore VP; Patel KD; Vora HH; Patel PS; Jain NK Arch Oral Biol; 2024 May; 161():105925. PubMed ID: 38442470 [TBL] [Abstract][Full Text] [Related]
15. Development and validation of a hypoxia-related gene pair signature to predict overall survival in head and neck squamous cell carcinoma. Ding Z; Li H; Yu D Eur Arch Otorhinolaryngol; 2021 Oct; 278(10):3973-3983. PubMed ID: 33449166 [TBL] [Abstract][Full Text] [Related]
16. Characterization of Cancer Stem Cell Characteristics and Development of a Prognostic Stemness Index Cell-Related Signature in Oral Squamous Cell Carcinoma. Feng J; Li Y; Wen N Dis Markers; 2021; 2021():1571421. PubMed ID: 34840626 [TBL] [Abstract][Full Text] [Related]
17. A pyroptosis-related lncRNA signature predicts prognosis and immune microenvironment in head and neck squamous cell carcinoma. Zhu W; Ye Z; Chen L; Liang H; Cai Q Int Immunopharmacol; 2021 Dec; 101(Pt B):108268. PubMed ID: 34688154 [TBL] [Abstract][Full Text] [Related]
18. Identification of prognostic genes in oral squamous cell carcinoma microenvironment. Zhu L; Zhang X; Chen Y; Yan D; Han J Cancer Biomark; 2022; 34(4):523-532. PubMed ID: 35275524 [TBL] [Abstract][Full Text] [Related]
19. Development and validation of a fourteen- innate immunity-related gene pairs signature for predicting prognosis head and neck squamous cell carcinoma. Zhang F; Liu Y; Yang Y; Yang K BMC Cancer; 2020 Oct; 20(1):1015. PubMed ID: 33081731 [TBL] [Abstract][Full Text] [Related]
20. Identification of an Immune Score-Based Gene Panel with Prognostic Power for Oral Squamous Cell Carcinoma. Huang SN; Li GS; Zhou XG; Chen XY; Yao YX; Zhang XG; Liang Y; Li MX; Chen G; Huang ZG; Dang YW; Li J; Li P; Tang XZ; Rong MH Med Sci Monit; 2020 Jun; 26():e922854. PubMed ID: 32529991 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]